| Product Code: ETC9387346 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 South Africa Neurodegenerative Disease Treatment Market Overview |
3.1 South Africa Country Macro Economic Indicators |
3.2 South Africa Neurodegenerative Disease Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 South Africa Neurodegenerative Disease Treatment Market - Industry Life Cycle |
3.4 South Africa Neurodegenerative Disease Treatment Market - Porter's Five Forces |
3.5 South Africa Neurodegenerative Disease Treatment Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 South Africa Neurodegenerative Disease Treatment Market Revenues & Volume Share, By Drug Type:, 2021 & 2031F |
3.7 South Africa Neurodegenerative Disease Treatment Market Revenues & Volume Share, By Route of Administration:, 2021 & 2031F |
3.8 South Africa Neurodegenerative Disease Treatment Market Revenues & Volume Share, By Distribution Channel:, 2021 & 2031F |
4 South Africa Neurodegenerative Disease Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of neurodegenerative diseases in South Africa |
4.2.2 Advancements in medical research leading to new treatment options |
4.2.3 Growing awareness and healthcare infrastructure for neurodegenerative diseases in the region |
4.3 Market Restraints |
4.3.1 High treatment costs and limited access to healthcare services |
4.3.2 Lack of specialized healthcare professionals for neurodegenerative diseases |
4.3.3 Regulatory challenges and approval processes for new treatments |
5 South Africa Neurodegenerative Disease Treatment Market Trends |
6 South Africa Neurodegenerative Disease Treatment Market, By Types |
6.1 South Africa Neurodegenerative Disease Treatment Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 South Africa Neurodegenerative Disease Treatment Market Revenues & Volume, By Indication, 2021- 2031F |
6.1.3 South Africa Neurodegenerative Disease Treatment Market Revenues & Volume, By Multiple Sclerosis, 2021- 2031F |
6.1.4 South Africa Neurodegenerative Disease Treatment Market Revenues & Volume, By Parkinsons Disease, 2021- 2031F |
6.1.5 South Africa Neurodegenerative Disease Treatment Market Revenues & Volume, By Alzheimers Disease, 2021- 2031F |
6.1.6 South Africa Neurodegenerative Disease Treatment Market Revenues & Volume, By Spinal Muscular Atrophy (SMA), 2021- 2031F |
6.1.7 South Africa Neurodegenerative Disease Treatment Market Revenues & Volume, By Huntingtons Disease, 2021- 2031F |
6.1.8 South Africa Neurodegenerative Disease Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.2 South Africa Neurodegenerative Disease Treatment Market, By Drug Type: |
6.2.1 Overview and Analysis |
6.2.2 South Africa Neurodegenerative Disease Treatment Market Revenues & Volume, By N-methyl-D-aspartate Receptor Antagonists, 2021- 2031F |
6.2.3 South Africa Neurodegenerative Disease Treatment Market Revenues & Volume, By Selective Serotonin Reuptake Inhibitors, 2021- 2031F |
6.2.4 South Africa Neurodegenerative Disease Treatment Market Revenues & Volume, By Dopamine Inhibitors, 2021- 2031F |
6.2.5 South Africa Neurodegenerative Disease Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.3 South Africa Neurodegenerative Disease Treatment Market, By Route of Administration: |
6.3.1 Overview and Analysis |
6.3.2 South Africa Neurodegenerative Disease Treatment Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 South Africa Neurodegenerative Disease Treatment Market Revenues & Volume, By Injectable, 2021- 2031F |
6.3.4 South Africa Neurodegenerative Disease Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.4 South Africa Neurodegenerative Disease Treatment Market, By Distribution Channel: |
6.4.1 Overview and Analysis |
6.4.2 South Africa Neurodegenerative Disease Treatment Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.4.3 South Africa Neurodegenerative Disease Treatment Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.4.4 South Africa Neurodegenerative Disease Treatment Market Revenues & Volume, By Others, 2021- 2031F |
7 South Africa Neurodegenerative Disease Treatment Market Import-Export Trade Statistics |
7.1 South Africa Neurodegenerative Disease Treatment Market Export to Major Countries |
7.2 South Africa Neurodegenerative Disease Treatment Market Imports from Major Countries |
8 South Africa Neurodegenerative Disease Treatment Market Key Performance Indicators |
8.1 Average patient wait time for neurodegenerative disease treatment |
8.2 Number of clinical trials and research studies conducted in the region |
8.3 Adoption rate of innovative treatment technologies |
8.4 Patient satisfaction and quality of life improvement measures |
8.5 Healthcare expenditure on neurodegenerative disease treatments |
9 South Africa Neurodegenerative Disease Treatment Market - Opportunity Assessment |
9.1 South Africa Neurodegenerative Disease Treatment Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 South Africa Neurodegenerative Disease Treatment Market Opportunity Assessment, By Drug Type:, 2021 & 2031F |
9.3 South Africa Neurodegenerative Disease Treatment Market Opportunity Assessment, By Route of Administration:, 2021 & 2031F |
9.4 South Africa Neurodegenerative Disease Treatment Market Opportunity Assessment, By Distribution Channel:, 2021 & 2031F |
10 South Africa Neurodegenerative Disease Treatment Market - Competitive Landscape |
10.1 South Africa Neurodegenerative Disease Treatment Market Revenue Share, By Companies, 2024 |
10.2 South Africa Neurodegenerative Disease Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here